# AbbVie Inc. (ABBV) FY2025 Q1 Balance Sheet

- Company: AbbVie Inc. (ABBV)
- Period: As of 2025-03-31
- Filing: Q1 FY2025 10-Q, filed 2025-05-09, accession number 0001551152-25-000029
- Page: https://plicit.ai/financials/abbv/fy2025-q1-balance-sheet
- Chart image: https://plicit.ai/charts/abbv-fy2025-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 136,165,000,000 US dollars
- **Current assets**: 27,675,000,000 US dollars
- **Non-current assets**: 108,490,000,000 US dollars
- **Liabilities (calculated)**: 134,703,000,000 US dollars
- **Current liabilities**: 36,403,000,000 US dollars
- **Non-current liabilities**: 98,300,000,000 US dollars
- **Equity**: 1,462,000,000 US dollars
- **Noncontrolling interest**: 42,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 12,477,000,000 US dollars
- **Prepaid expenses and other**: 5,496,000,000 US dollars
- **Cash and equivalents**: 5,175,000,000 US dollars
- **Inventories**: 4,526,000,000 US dollars
- **Short-term investments**: 1,000,000 US dollars
- **Intangible assets, net**: 58,489,000,000 US dollars
- **Goodwill**: 35,285,000,000 US dollars
- **Other assets**: 9,192,000,000 US dollars
- **Property and equipment, net**: 5,237,000,000 US dollars
- **Investments**: 287,000,000 US dollars
- **Accounts payable and accrued liabilities**: 31,041,000,000 US dollars
- **Current portion of long-term debt and finance lease obligations**: 3,769,000,000 US dollars
- **Short-term borrowings**: 1,593,000,000 US dollars
- **Long-term debt and finance lease obligations**: 64,527,000,000 US dollars
- **Other long-term liabilities**: 31,191,000,000 US dollars
- **Deferred income taxes**: 2,582,000,000 US dollars
- **Additional paid-in capital**: 21,808,000,000 US dollars
- **Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,837,071,074 shares issued as of March 31, 2025 and 1,831,594,494 as of December 31, 2024**: 18,000,000 US dollars
- **Noncontrolling interest**: 42,000,000 US dollars
- **Accumulated deficit**: negative 9,527,000,000 US dollars
- **Common stock held in treasury, at cost, 70,782,695 shares as of March 31, 2025 and 66,337,508 as of December 31, 2024**: negative 9,137,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 1,742,000,000 US dollars
- **Gross equity (calculated)**: 21,868,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.